By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



7000 Shoreline Court
Suite 371
South San Francisco  California  94080  U.S.A.
Phone: 650-266-1120 Fax: 650-266-1130




Company News
Achaogen (AKAO) To Present At 2014 Credit Suisse Healthcare Conference 10/29/2014 7:23:40 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $4 Million From Achaogen (AKAO) For The Initiation Of A Phase 3 Study Of Plazomicin 9/17/2014 8:30:18 AM
Achaogen (AKAO) Announces First Patient Enrollment In A Phase 3 Clinical Trial Of Plazomicin To Treat Infections Caused By Carbapenem-Resistant Enterobacteriaceae (CRE) 9/17/2014 7:48:43 AM
Achaogen (AKAO) Announces Second Quarter 2014 Results 8/11/2014 4:57:51 PM
Achaogen (AKAO) Appoints Dr. Ian Friedland As Chief Medical Officer 7/14/2014 6:01:36 AM
Achaogen (AKAO) Announces First Quarter 2014 Results 5/12/2014 9:58:15 AM
Achaogen (AKAO) To Present At 13th Annual Needham Healthcare Conference 4/7/2014 9:08:39 AM
Achaogen (AKAO) Appoints Chris Boerner To Board Of Directors 4/2/2014 9:28:06 AM
Achaogen (AKAO) Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Over-Allotment Option To Purchase Additional Shares 3/18/2014 8:59:20 AM
Antibacterial Biotech Achaogen Sets Terms For $65 Million IPO 2/25/2014 7:39:21 AM